Pherecydes Pharma

French, early-stage biotech developing bacteriophage treatments against multi-drug resistant bacterial infections

placeRomainville, Ile De France, France calendar_todayFounded 2006 groups27 employees language pherecydes-pharma.com

Innovation

7 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 651 times.

YearFilings
20133
20141
20153
20165
20175
20183
20194
20204
20214
20222
20234
20243

Investor mix

11 investors on record; lead investors include Auriga Partners, GO CAPITAL, ACE Management.

Investor typeCountShare
Venture capital218%
Private equity327%
Accelerator & incubator19%
Other / undisclosed545%
Coming soon